Post-approval studies (Phase 4)Active Not RecruitingNCT05622708
What this trial is testing
Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved Remission
Who this might be right for
Non-radiographic Axial Spondyloarthritis
Novartis Pharmaceuticals 240